Literature DB >> 10760102

Multistate outbreak of hemolysis in hemodialysis patients traced to faulty blood tubing sets.

R Duffy1, K Tomashek, M Spangenberg, L Spry, D Dwyer, T J Safranek, C Ying, D Portesi, H Divan, J Kobrenski, M Arduino, J Tokars, W Jarvis.   

Abstract

BACKGROUND: Hemolysis associated with hemodialysis is rare. The most frequent causes of hemodialysis-associated hemolysis are chemical contamination, heat, or mechanical injury of erythrocytes from occluded or kinked hemodialysis blood lines. When patients in three states developed hemolysis while undergoing hemodialysis between May 13 and 23, 1998, an investigation was initiated.
METHODS: A case-patient was defined as any patient at healthcare facilities A (Nebraska), B (Maryland), or C (Massachusetts) during May 13 through 23, 1998 (epidemic period), who had hemolysis diagnosed > or =48 hours after undergoing hemodialysis. To identify case-patients and to determine background rates, the medical records of patients from facilities A, B, and C who were undergoing hemodialysis during the epidemic and pre-epidemic (that is, May 5 through 19, 1998) periods were reviewed. Experiments simulating hemodialysis with the same lot numbers of hemodialysis blood tubing cartridge sets used on case- and control-patients were conducted.
RESULTS: The rates of hemolysis among patients at facilities A, B, and C were significantly higher during the epidemic than the pre-epidemic period (13 out of 118 vs. 0 out of 118, P < 0.001; 12 out of 298 vs. 0 out of 298, P = 0.001; and 5 out of 62 vs. 0/65, P = 0.03, respectively). All case-patients had hemolysis. Twenty (66%) had hypertension. Eighteen (60%) had abdominal pain, and 10 (36%) were admitted to an intensive care unit. There were two deaths. The only commonality among the three outbreaks was the use of the same lot of disposable hemodialysis blood tubing from one manufacturer. Examination of the implicated hemodialysis blood tubing cartridge sets revealed narrowing of an aperture through which blood was pumped before entering the dialyzers. In vitro experiments with the hemodialysis blood tubing revealed that hemolysis was caused by increased pressure on erythrocytes as they passed through the partially occluded hemodialysis blood tubing.
CONCLUSIONS: Our investigation traced the multiple hemolysis outbreaks to partially occluded hemodialysis blood tubing produced by a single manufacturer. On May 25, 1998, the manufacturer issued a voluntary nationwide recall of the implicated lots of hemodialysis blood tubing cartridge sets.

Entities:  

Mesh:

Year:  2000        PMID: 10760102     DOI: 10.1046/j.1523-1755.2000.00011.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Diagnosis, Treatment, and Prevention of Hemodialysis Emergencies.

Authors:  Manish Saha; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-09       Impact factor: 8.237

2.  Performance characteristics of a novel blood bag in-line closure device and subsequent product quality assessment.

Authors:  Katherine Serrano; Elena Levin; Brankica Culibrk; Sandra Weiss; Ken Scammell; Wolfgang F Boecker; Dana V Devine
Journal:  Transfusion       Date:  2010-08-16       Impact factor: 3.157

3.  Hemolysis as a rare but potentially life-threatening complication of hemodialysis: a case report.

Authors:  Jenni Yoon; Sritika Thapa; Robert Dobbin Chow; Bernard G Jaar
Journal:  BMC Res Notes       Date:  2014-07-28

4.  Mechanical haemolysis related to the use of tandem dialyzers.

Authors:  Asif Kazmi; Robert Canada; Barry M Wall
Journal:  NDT Plus       Date:  2008-01-04

5.  In Vitro Comparative Assessment of Mechanical Blood Damage Induced by Different Hemodialysis Treatments.

Authors:  Ranko Sakota; Carlo Alberto Lodi; Sara Antonia Sconziano; Werner Beck; Juan P Bosch
Journal:  Artif Organs       Date:  2015-05-15       Impact factor: 3.094

6.  Hemolysis in a Patient during Hemodialysis.

Authors:  Maxime Taghavi; Lucas Jacobs; Saleh Kaysi; Maria do Carmo Filomena Mesquita
Journal:  Case Rep Nephrol Dial       Date:  2021-11-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.